Acute Generalized Exanthematous Pustulosis Complicated by Acute Tubular Necrosis: Case Report
DOI:
https://doi.org/10.22517/25395203.25840Keywords:
Meropenem, Vancomycin, Severe cutaneous adverse reactions, Acute generalized, Exanthematous pustulosisAbstract
Acute generalized exanthematous pustulosis (AGEP) is a severe cutaneous adverse reaction characterized by the rapid onset of non-follicular sterile pustules on an erythematous base. In most cases, it is associated with drug administration, with antibiotics being the most frequently implicated, although a wide range of medications can trigger this condition. Typically, within 48 hours after exposure to the causal drug, fever and pustular eruption accompanied by leukocytosis occur. We present the case of a 57-year-old man admitted to the hospital with a right foot ulcer, who after several days of treatment with meropenem and vancomycin developed a generalized skin rash with fever, leukocytosis with eosinophilia, and acute kidney injury. A skin biopsy confirmed the diagnosis of AGEP. The patient received treatment with methylprednisolone pulses, hydroxyzine, and topical mupirocin, which led to significant clinical improvement and allowed hospital discharge. This case highlights the importance of early recognition of severe antibiotic-induced cutaneous reactions and their potential association with systemic complications such as acute tubular necrosis, underscoring the need for timely diagnostic and therapeutic interventions to reduce morbidity and mortality.
Downloads
References
Ghoshal L, Nandi S, Sarkar A, Das S. Acute generalized exanthematous pustulosis due to meropenem: an unusual side effect of a commonly used drug. Indian Dermatol Online J. 2015;6(6):446-8.
Feldmeyer L, Heidemeyer K, Yawalkar N. Acute generalized exanthematous pustulosis: pathogenesis, genetic background, clinical variants and therapy. Int J Mol Sci. 2016;17(8):1214.
Chang SL, Huang YH, Yang CH, Hu S, Hong HS. Clinical manifestations and characteristics of patients with acute generalized exanthematous pustulosis in Asia. Acta Derm Venereol. 2008;88(4):363-5.
Nantes Castillejo Ó, Zozaya Urmeneta JM, Valcayo Peñalba A, Martínez-Peñuela Virseda JM. Pustulosis exantemática aguda generalizada inducida por omeprazol. Gastroenterol Hepatol. 2008;31(5):295-8.
Saissi EH, Beau-Salinas F, Jonville-Béra AP, Lorette G, Autret-Leca E, Centres Régionaux de Pharmacovigilance. Drugs associated with acute generalized exanthematous pustulosis. Ann Dermatol Venereol. 2003;130(6-7):612-8.
Rajgopal Bala H, Jalilian C, Goh MS, Williams R, Tan G, Chong AH. Two cases of amoxycillin-induced follicular acute
localised exanthematous pustulosis. Australas J Dermatol. 2017;58(1):e23-5.
Moreno-Arrones OM, Carrillo-Gijon R, Sendagorta E, Rios-Buceta L. Acute generalized exanthematous pustulosis simulating Stevens-Johnson syndrome/toxic epidermal necrolysis associated with the use of vismodegib. JAAD Case Rep. 2018;4(2):123-5.
Ladhari C, Mokni S, Fathallah N, Zariaa S, Boussofara L, Aounallah A, et al. An unusual photodistributed acute generalized exanthematous pustulosis induced by terbinafine. Therapies. 2019;74(4):502-4.
Oh DAQ, Yeo YW, Choo KJL, Pang SM, Oh CC, Lee HY. Acute generalized exanthematous pustulosis: epidemiology,
clinical course, and treatment outcomes of patients treated in an Asian academic medical center. JAAD Int. 2021;3:1-6.
Mofarrah R, Oshriehye M, Ghobadi Aski S, Nazemi N, Nooshiravanpoor P. The necessity of patch testing in determining the causative drug of AGEP. J Cosmet Dermatol. 2021;20(7):2156-9.
Gallardo MA, Mallela T, Gilkey T, Himed S, Walker TD, Nusbaum KB, et al. Demographic and laboratory differences seen between acute generalized exanthematous pustulosis and drug reaction with eosinophilia and systemic symptoms: a cross-sectional analysis. J Am Acad Dermatol. 2023;88(5):1142-5.
Parisi R, Shah H, Navarini AA, Muehleisen B, Ziv M, Shear NH, et al. Acute generalized exanthematous pustulosis: clinical features, differential diagnosis, and management. Am J Clin Dermatol. 2023;24:1-19.
Henning MA, Opstrup MS, Taudorf EH. Acute generalized exanthematous pustulosis to amoxicillin. Dermatitis.
;30(4):274-5.
Pettit C, Trinidad J, Kaffenberger B. A case of vancomycin-induced acute generalized exanthematous pustulosis confirmed by patch testing. J Clin Aesthet Dermatol. 2020;13(11):35-6.
Aiempanakit K, Apinantriyo B. Clindamycin-induced acute generalized exanthematous pustulosis: a case report. Medicine (Baltimore). 2020;99(21):e20389.
Szatkowski J, Schwartz RA. Acute generalized exanthematous pustulosis (AGEP): a review and update. J Am Acad Dermatol.2015;73(5):843-8.
Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC. Acute generalized exanthematous pustulosis (AGEP): a clinical reaction pattern. J Cutan Pathol. 2001;28(3):113-9.
Kostopoulos TC, Krishna SM, Brinster NK, Ortega-Loayza AG. Acute generalized exanthematous pustulosis: atypical presentations and outcomes. J Eur Acad Dermatol Venereol. 2015;29(2):209-14.
Speeckaert MM, Speeckaert R, Lambert J, Brochez L. Acute generalized exanthematous pustulosis: an overview of the clinical, immunological and diagnostic concepts. Eur J Dermatol. 2010;20(4):425-33.
Downloads
-
Vistas(Views): 1
- PDF (Español (España)) Descargas(Downloads): 1
Published
How to Cite
Issue
Section
License
Cesión de derechos y tratamiento de datos
La aceptación de un artículo para su publicación en la Revista Médica de Risaralda implica la cesión de los derechos de impresión y reproducción, por cualquier forma y medio, del autor a favor de Facultad de Ciencias de la Salud de la Universidad Tecnológica de Pereira. 1995-2018. Todos los derechos reservados ®
por parte de los autores para obtener el permiso de reproducción de sus contribuciones. La reproducción total o parcial de los trabajos aparecidos en la Revista Médica de Risaralda, debe hacerse citando la procedencia, en caso contrario, se viola los derechos reservados.
Asimismo, se entiende que los conceptos y opiniones expresados en cada trabajo son de la exclusiva responsabilidad del autor, sin responsabilizarse ni solidarizarse, necesariamente, ni la redacción, ni la editorial.
Es responsabilidad de los autores poder proporcionar a los lectores interesados copias de los datos en bruto, manuales de procedimiento, puntuaciones y, en general, material experimental relevante.
Asimismo, la Dirección de la revista garantiza el adecuado tratamiento de los datos de carácter personal